Written question asked by Rebecca Long Bailey (Labour) on Tuesday, 1 October 2019, in the House of Commons. It was due for an answer on Thursday, 3 October 2019. It was answered by Edward Argar (Conservative) on Tuesday, 8 October 2019 on behalf of the Department of Health and Social Care.
Cancer: Children
- Question
-
To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure that medicines to treat cancer in children are available in the event that the UK leaves the EU without a deal.
- Answer
-
The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including those to treat cancer in children, once we have left the EU.
The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:
Secondary information
- Type
- Written question
- Reference
- 292923
- Session
- 2017-19
- Subjects
- Children Cancer Drugs Brexit
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-10-08 19:59:35 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/292923
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/292923
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/292923